Retacrit® Epoetin Alfa-epbx 2,000 U/mL Injection - Single-Dose Vial for Anemia Management
USAMP#72712634SKU: 00069130510Retacrit®
License Required
Product Spotlight
- Manufactured by Pfizer Biosimilar, ensuring high-quality and reliability.
- Contains Epoetin Alfa-epbx, a biosimilar to Epogen®/Procrit®, used to treat anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in HIV patients.
- Available in a 2,000 U/mL strength for precise dosage according to medical requirements.
- Comes in a single-dose vial of 1 mL, designed for single use to ensure safety and sterility.
- Classified as a Hematopoietic Agent, it stimulates red blood cell production.
- Storage requires refrigeration to maintain its efficacy and extend shelf life.
